Evidence map›Paper›PMID 40807149›Full record

ReviewJournal of clinical medicine2025

Redefining Treatment Paradigms in Thyroid Eye Disease: Current and Future Therapeutic Strategies.

Nicolò Ciarmatori, Flavia Quaranta Leoni, Francesco M Quaranta Leoni

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Gypenosides attenuate HAmerican journal of translational research · 2026
    Article
  5. Editorial: Thyroid eye disease.Frontiers in ophthalmology · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicolò CiarmatoriDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Flavia Quaranta LeoniOphthalmology Unit, Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Francesco M Quaranta LeoniDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graves’ orbitopathyinsulin-like growth factor-1 receptor (IGF-1R) inhibitorsneonatal Fc receptor (FcRn) inhibitorsteprotumumabthyroid-associated orbitopathy (TAO)thyroid eye disease (TED)

Identifiers

PMID40807149
PMCPMC12347536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.